| Name | Title | Contact Details |
|---|
GD USA is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Merit Medical Systems, Inc is a leading manufacturer of medical devices used in diagnostic and interventional cardiology and radiology procedures. Its primary products consist of inflation devices used in angioplasty, stent placement and discography; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; guide wires used to place balloon angioplasty catheters within a patient`s coronary arteries; products used to manage and monitor the administration of contrast and other fluid solutions during diagnostic and therapeutic procedures; thrombolytic catheters and fluid dispensing systems; angiography accessories; and standard and custom angiography kits. Headquartered in South Jordan, Utah, a suburb of Salt Lake City, Merit employs approximately 1,900 people worldwide. Merit markets its products in the United States and Europe (direct sales force) and the world (distributors). They call directly on physicians and clinicians in hospitals and clinics worldwide. The Company has expanded to three separate facilities in the Salt Lake City, Utah area (South Jordan, Murray and West Jordan). Merit also has facilities in Galway, Ireland (guidewires), Angleton, Texas (catheters), in Richmond, Virginia (procedural trays and packs) and a customer service and distribution center in Maastricht, The Netherlands. The Company has achieved a world leadership position in inflation devices and hemostasis valves and is renowned for its product innovation, customer service and product quality. Merit possesses a proprietary manufacturing process which allows it to offer contract manufacturing (OEM) to a wide range of medical device companies. Merit Endotek is a newly created division of Merit. These products are focused in the gastroenterology medical device market. The products include stent technology in the emerging field of non-vascular interventional stenting. This next-generation stent technology is used in the lungs, esophagus, and biliary tract.
VeriTeQ's core technology evolved from implantable radio frequency identification (RFID) microchip technology used in the health care community for over two decades. This first-of-its-kind implantable RFID technology was cleared for use by the FDA in 2004 as a Class II medical device, originally to identify at-risk patients at the point of care. It has now evolved to help medical device manufacturers meet mandatory regulations outlined in the FDA's Safety & Innovation Act, signed into law in July 2012, and the FDA's Unique Device Identification (UDI) Final Rule. This technology is VeriTeQ's Q Inside Safety Technology. VeriTeQ's dosimeter technologies are used in the oncology suite and give an oncology team the ability to measure the dosage of radiation delivered to a patient on a per treatment basis. The data collected from our dosimeter technologies is invaluable when recording the total amount of radiation that a patient is exposed to during the entire treatment regimen, and the data can be used on a generic basis to develop future treatment regimens and evidence-based healthcare. VeriTeQ is developing an informatics and data analytics platform that will improve the type of medical device and treatment regimen data that can be used in many applications to improve patient healthcare and outcomes. Such examples include using VeriTeQ's UDI data in supply chain management for medical device manufacturers and healthcare institutions, quality and reimbursement controls for hospitals, and treatment regimen data for patients receiving chemotherapy and radiation therapy. VeriTeQ owns a rich portfolio of intellectual property protecting all of its current and future technologies.
Carrollton Eye Clinic Pc is a Carrollton, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
iData Research Inc. is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.